Financials
- Market Capitalization 11.44 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.30 USD | +0.33% | -4.20% | +5.96% | -22.96% | 11.88 B USD | ||
| 828 | AXSM Axsome Therapeutics, Inc. - Common Stock | 228.28 USD | -2.36% | -5.79% | -10.25% | +75.33% | 11.75 B USD | ||
| 858 | TECH Bio-Techne Corp - Common Stock | 71.36 USD | +0.08% | +0.62% | +29.02% | +34.67% | 11.17 B USD | ||
| 878 | KRYS Krystal Biotech, Inc. - Common Stock | 363.44 USD | -0.65% | -3.21% | +14.29% | +94.22% | 10.71 B USD |
Frequently asked questions about BioMarin Pharmaceutical Inc. - Common Stock
What is the BioMarin Pharmaceutical Inc. - Common Stock stock price today?
The current price of BioMarin Pharmaceutical Inc. - Common Stock (BMRN) is 59.2. Over the past 24 hours, the stock has changed by +0.14%. Follow the BMRN chart for real-time price dynamics.
What is the stock ticker of BioMarin Pharmaceutical Inc. - Common Stock?
BioMarin Pharmaceutical Inc. - Common Stock trades under the ticker BMRN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioMarin Pharmaceutical Inc. - Common Stock stock going up?
BMRN has changed by -0.74% over the last week, +5.56% over the last month, and +1.02% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BioMarin Pharmaceutical Inc. - Common Stock net income for the last quarter?
BioMarin Pharmaceutical Inc. - Common Stock reported net income of 105.53 M for the last quarter. The previous quarter showed -46.57 M, which means net income changed by +326.58%.
How many employees does BioMarin Pharmaceutical Inc. - Common Stock have?
As of the latest available data, BioMarin Pharmaceutical Inc. - Common Stock has 3 221 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioMarin Pharmaceutical Inc. - Common Stock EBITDA?
BioMarin Pharmaceutical Inc. - Common Stock EBITDA is 146.05 M, and its EBITDA margin is 19.06%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioMarin Pharmaceutical Inc. - Common Stock stock?
You can buy BioMarin Pharmaceutical Inc. - Common Stock (BMRN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioMarin Pharmaceutical Inc. - Common Stock stock?
Investing in BioMarin Pharmaceutical Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BMRN chart and related analysis on metatrader.com as part of your research.